| Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders O Devinsky, MR Cilio, H Cross, J Fernandez‐Ruiz, J French, C Hill, ... Epilepsia 55 (6), 791-802, 2014 | 1112 | 2014 |
| Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage YL Hurd, M Yoon, AF Manini, S Hernandez, R Olmedo, M Ostman, ... Neurotherapeutics 12 (4), 807-815, 2015 | 209 | 2015 |
| The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street‐drug users J Bruneau, É Roy, N Arruda, G Zang, D Jutras‐Aswad Addiction 107 (7), 1318-1327, 2012 | 209 | 2012 |
| Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome D Jutras-Aswad, JA DiNieri, T Harkany, YL Hurd European archives of psychiatry and clinical neuroscience 259, 395-412, 2009 | 189 | 2009 |
| Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence M Prud'homme, R Cata, D Jutras-Aswad Substance abuse: research and treatment 9, SART. S25081, 2015 | 188 | 2015 |
| Trajectory of adolescent cannabis use on addiction vulnerability YL Hurd, M Michaelides, ML Miller, D Jutras-Aswad Neuropharmacology 76, 416-424, 2014 | 160 | 2014 |
| Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans AF Manini, G Yiannoulos, MM Bergamaschi, S Hernandez, R Olmedo, ... Journal of addiction medicine 9 (3), 204-210, 2015 | 130 | 2015 |
| Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update B Fischer, T Robinson, C Bullen, V Curran, D Jutras-Aswad, ... International Journal of Drug Policy 99, 103381, 2022 | 110 | 2022 |
| Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study J Bruneau, G Zang, M Abrahamowicz, D Jutras-Aswad, M Daniel, É Roy Clinical infectious diseases 58 (6), 755-761, 2014 | 85 | 2014 |
| Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis ME Socías, T Kerr, E Wood, H Dong, S Lake, K Hayashi, K DeBeck, ... Addictive behaviors 72, 138-143, 2017 | 79 | 2017 |
| Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia JM Cerimele, AP Stern, D Jutras-Aswad American Journal of Psychiatry 167 (3), 353-353, 2010 | 69 | 2010 |
| Associations of substance use patterns with attempted suicide among persons who inject drugs: can distinct use patterns play a role? AA Artenie, J Bruneau, G Zang, F Lespérance, J Renaud, J Tremblay, ... Drug and alcohol dependence 147, 208-214, 2015 | 52 | 2015 |
| Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction S Olière, A Jolette-Riopel, S Potvin, D Jutras-Aswad Frontiers in psychiatry 4, 109, 2013 | 52 | 2013 |
| Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement AA Artenie, D Jutras‐Aswad, É Roy, G Zang, JM Bamvita, A Lévesque, ... Journal of Viral Hepatitis 22 (10), 792-799, 2015 | 44 | 2015 |
| Cannabis-dependence risk relates to synergism between neuroticism and proenkephalin SNPs associated with amygdala gene expression: case-control study D Jutras-Aswad, MM Jacobs, G Yiannoulos, P Roussos, P Bitsios, ... PloS one 7 (6), e39243, 2012 | 44 | 2012 |
| Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo‐controlled trial V Mongeau‐Pérusse, S Brissette, J Bruneau, P Conrod, S Dubreucq, ... Addiction 116 (9), 2431-2442, 2021 | 43 | 2021 |
| Effects of cannabidiol on morphine conditioned place preference in mice JR Markos, HM Harris, W Gul, MA ElSohly, KJ Sufka Planta medica 84 (04), 221-224, 2018 | 42 | 2018 |
| Epidemiology of injection drug use: new trends and prominent issues É Roy, N Arruda, J Bruneau, D Jutras-Aswad The Canadian Journal of Psychiatry 61 (3), 136-144, 2016 | 42 | 2016 |
| Reversing the atypical valuation of drug and nondrug rewards in smokers using multimodal neuroimaging TE Baker, P Lesperance, A Tucholka, S Potvin, K Larcher, YU Zhang, ... Biological psychiatry 82 (11), 819-827, 2017 | 37 | 2017 |
| Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis T Robinson, MU Ali, B Easterbrook, W Hall, D Jutras-Aswad, B Fischer Psychological medicine 53 (9), 3858-3868, 2023 | 35 | 2023 |
